Thus, it would be interesting to quantify miR‐34a levels upon doxorubicin treatment to characterize the role of miR‐34a on AXL expression in mesenchymal‐type lung cancer cells compared with epithelial cancer cells. This evidence concerns the gene AXL and lung cancer.